2002
DOI: 10.4314/tjog.v19i1.14363
|View full text |Cite
|
Sign up to set email alerts
|

HIV in Pregnancy: Experience at Abeokuta, Nigeria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
8
2

Year Published

2009
2009
2020
2020

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 0 publications
1
8
2
Order By: Relevance
“…This highlights the important role the ANC plays in PMTCT and also in reducing the incidence of HIV/AIDS particularly in communities like ours where the ANC may be the only setting where women have contact with health personnel. The prevalence rate reported in this study is higher than those reported from most other Nigerian centers (Fawole et al, 2002, Ojukwu and Ibekwe, 2005, Ikechebelu et al, 2006 and much higher than the rates reported from the developed world (Lehtouitra et al 2005). This is probably a direct reflection of the situation in the state as the recent national HIV sentinel survey revealed a seroprevalence of 8.0 in the state.…”
Section: Discussioncontrasting
confidence: 69%
“…This highlights the important role the ANC plays in PMTCT and also in reducing the incidence of HIV/AIDS particularly in communities like ours where the ANC may be the only setting where women have contact with health personnel. The prevalence rate reported in this study is higher than those reported from most other Nigerian centers (Fawole et al, 2002, Ojukwu and Ibekwe, 2005, Ikechebelu et al, 2006 and much higher than the rates reported from the developed world (Lehtouitra et al 2005). This is probably a direct reflection of the situation in the state as the recent national HIV sentinel survey revealed a seroprevalence of 8.0 in the state.…”
Section: Discussioncontrasting
confidence: 69%
“…The prevalence rate of 5.04% among pregnant women in this study is higher than the National prevalence rate of 4.6% (FMoH, 2009) and also higher than those reported from other centres in Nigeria (Bassey et al, 2007;Fawole et al, 2002;Ojukwu and Ibekwe, 2005;Ikechebelu and Udigwe, 2006).…”
Section: Discussioncontrasting
confidence: 48%
“…The use of HAART in pregnancy has shown remarkable improvement in immune status and reduction of MTCT of HIV infection [1] but some adverse pregnancy conditions have been seen in some studies [2,3,4]. These include preterm delivery, low birth weight and gestational diabetes.…”
Section: Introductionmentioning
confidence: 99%